Statement Of Financial Position [Abstract]

ABIONYX Pharma - Filing #2810725

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment
335,000 EUR
373,000 EUR
Goodwill
5 377 EUR
5 377 EUR
Intangible assets other than goodwill
80,000 EUR
75,000 EUR
Non-current assets
7 948 EUR
8 251 EUR
Current assets [abstract]
Current inventories
221,000 EUR
147,000 EUR
Cash and cash equivalents
4 104 EUR
4 046 EUR
Current assets
6 886 EUR
7 572 EUR
Assets
14 834 EUR
15 823 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
1 623 EUR
1 418 EUR
Share premium
12 572 EUR
8 599 EUR
Equity
158,000 EUR
7 922 EUR
6 341 EUR
12 572 EUR
1 623 EUR
103,000 EUR
193,000 EUR
7 169 EUR
192,000 EUR
8 599 EUR
2 937 EUR
229,000 EUR
1 418 EUR
126,000 EUR
201,000 EUR
169 829 EUR
10 677 EUR
10,000 EUR
179 214 EUR
87,000 EUR
1 396 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current provisions [abstract]
Non-current provisions for employee benefits
412,000 EUR
417,000 EUR
Non-current liabilities
2 987 EUR
3 560 EUR
Current liabilities [abstract]
Current provisions [abstract]
Current provisions
0 EUR
931,000 EUR
Other current non-financial liabilities
1 671 EUR
1 440 EUR
Current liabilities
3 925 EUR
5 094 EUR
Equity and liabilities
14 834 EUR
15 823 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.